Isotretinoin Soft Capsules Acknowledgement of Risk Form
For Healthcare Professionals
Isotretinoin soft capsules Acknowledgement of Risk Form
Back to top
Risk Minimisation Materials
Search by company, common medicine name, or title of Risk Minimisation Material
Isotretinoin
Ennogen IP Ltd
For Healthcare Professionals
Isotretinoin Soft Capsules Patient Reminder Card
For Healthcare Professionals
Patient Reminder Card for Isotretinoin
Isotretinoin Soft Capsules Pharmacist Checklist
For Healthcare Professionals
Isotretinoin-GB-RMM- PC Ver 1.0 September 2025 MHRA Approval Date: September 2025
Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Isotretinoin Acknowledgement of Risk Form
For Healthcare Professionals
Isotretinoin Acknowledgement of Risk Form
Patient Reminder Card-Isotretinoin
This Patient Reminder Card contains important safety information for patients prescribed isotretinoin. It highlights the serious risks of pregnancy during isotretinoin treatment, contraception requirements, pregnancy testing, mental health monitoring, blood donation restrictions, and other key safety information. Patients should read this card together with the package leaflet before starting treatment and throughout treatment.
Pharmacist checklist-Isotretinoin
For Healthcare Professionals
Pharmacist Checklist Guidance for Dispensing Oral Isotretinoin
Roaccutane
Neon Healthcare Ltd
Isotretinoin Acknowledgement of Risk Form
For Healthcare Professionals
Updated Isotretinoin Acknowledgement of Risk Form
Pharmacist Checklist Guidance for Dispensing Oral Isotretinoin
For Healthcare Professionals
Guidance for the Pharmacist when Dispensing Oral Isotretinoin
You are trying to reach a document intended for healthcare professionals only.
Are you a healthcare professional?
